NCT06942403

In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re Epidermization

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Pierre Fabre Dermo Cosmetique · Industry
• Sex: All
• Age: 35 Years – 70 Years
• Healthy volunteers: Accepted

Summary

The aim of this study is to assess the dermatological tolerance of the investigational product "Crème visage Product code: RV4983A / Formula code: LA3365" after 95 days for subjects post peeling and LASER and 176 days for subjects post injections of once daily use at the evening on the half face, under normal conditions of use, on 66 subjects. This study will be conducted as a national, monocentric, open trial. Planning of the visits: * Visit 1: Inclusion (Day 1) - The subjects undergo their procedure (peeling, LASER or injections). * Home application of the associated product 1 period: Day 1 to Day 7 * Visit 2: intermediate visit (Day 8) subjects received investigational product and associated product 2; * Visit 3, 4, and 5: Intermediate visit (Day 37, Day 66 and Day 95\*), \*the final visit for the subjects post peeling and LASER * Visit 6\*\*: End of study (Day 176), \*\* for subjects post injections

Conditions

• Healthy

Interventions

Type	Name	Description
OTHER	Associated product 1 : RV2666C	Applied twice a day minimum during 7 days (from Day 1 to Day 7)
OTHER	Associated product 2 MORNING : RV5000A	Applied in the mornings from Day 8 to Day 95 or Day 176\* \* for subjects post injections
OTHER	Test product : RV4983A	Applied once a day, at the evening. Avoid contact with eyes. If sensations of discomfort appear, allow more time between applications. * From Day 8 to Day 95 (87 days) for post LASER and post peeling subjects * From Day 8 to Day 176 (169 days) for post-injections subjects
OTHER	Associated product 2 EVENING: RV5000A	Applied in the evenings from Day 8 to Day 95 or Day 176\* \* for subjects post injections

Timeline

• Start date: 2023-09-27
• Primary completion: 2024-03-26
• Completion: 2024-03-26
• First posted: 2025-04-24
• Last updated: 2025-04-24

Locations

1 site across 1 country: Poland